Karyopharm Therapeutics (KPTI) Other Operating Expenses (2019 - 2026)
Karyopharm Therapeutics (KPTI) posted Other Operating Expenses of $1.09 million for Q2 2026, up 3.2% from $1.05 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Other Operating Expenses (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Other Operating Expenses at Karyopharm Therapeutics was $5.73 million, up 15.1% year-over-year; for FY2025, it came in at $5.95 million, down 1.0% from FY2024.
- Annual Other Operating Expenses shows a five-year compound annual growth rate of 17.1% (FY2020 to FY2025).
- In prior years, Karyopharm Therapeutics' Other Operating Expenses was $6.01 million in FY2024 (+21.5%), $4.94 million in FY2023 (-5.2%), $5.21 million in FY2022 (+53.2%) and $3.4 million in FY2021 (+25.8%).
- Quarterly Other Operating Expenses has run from a low of $589,000 in Q3 2021 to a high of $2.11 million in Q3 2025 over five years.
- On a year-over-year basis, Other Operating Expenses increased in four of the last seven quarters, with growth averaging 7.1%.
- The strongest year-over-year quarter for Other Operating Expenses in the past five years was Q4 2022, with growth of 151.8%; the weakest was Q1 2025, with a decline of 31.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Karyopharm Therapeutics | 578,759.99 | -265.00 Mn | 32.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.33 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 1.49 Mn |
| Sep 30, 2023 | 911,000.00 |
| Jun 30, 2023 | 1.19 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 980,000.00 |
| Jun 30, 2022 | 939,000.00 |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 742,000.00 |
| Sep 30, 2021 | 589,000.00 |
API Access
Karyopharm Therapeutics Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();